Figure 1.
The proposed conceptual pathogenetic model includes the disease of obesity as the clinical endpoint, satiation as the surrogate endpoint, and gastric motor functions and gastrointestinal hormones as biomarkers or endophenotype, subject to modulation by the genotype.